Portal de investigação
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Yoo, Sang Gune K.
- Chung, Grace S.
- Bahendeka, Silver K.
- Sibai, Abla M.
- Damasceno, Albertino
- Farzadfar, Farshad
- Rohloff, Peter
- Houehanou, Corine
- Norov, Bolormaa
- Karki, Khem B.
- Azangou-Khyavy, Mohammadreza
- Marcus, Maja E.
- Aryal, Krishna K.
- Brant, Luisa C. C.
- Theilmann, Michaela
- Cifkova, Renata
- Gurung, Mongal S.
- Mwangi, Joseph Kibachio
- Martins, Joao
- Haghshenas, Rosa
- Sturua, Lela
- Vollmer, Sebastian
- Barnighausen, Till
- Atun, Rifat
- Sussman, Jeremy B.
- Singh, Kavita
- Moghaddam, Sahar Saeedi
- Guwatudde, David
- Geldsetzer, Pascal
- Manne-Goehler, Jennifer
- Huffman, Mark D.
- Davies, Justine I.
- Flood, David
Unidades de investigação
Abstract
The role of aspirin in the primary prevention of atherosclerotic cardiovascular disease (CVD) is not clear, with recent clinical trials evaluating aspirin for primary prevention demonstrating both modest benefits and risks associated with its use [1]. Aspirin is not routinely recommended for primary prevention of CVD. Understanding patterns of aspirin use can inform strategies to promote guideline-concordant therapy, including de-implementation strategies to reduce unnecessary aspirin use. This study seeks to provide an updated estimate of worldwide aspirin use for primary prevention of CVD. © 2024 The Author(s).
Dados da publicação
- ISSN/ISSNe:
- 2211-8179, 2211-8160
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.5334/gh.1323
- Link para outro recurso:
- www.scopus.com
Global Heart Elsevier Science & Technology
Documentos
- Não há documentos
Filiações
Keywords
- Aged; Aspirin; Cardiovascular Diseases; Cross-Sectional Studies; Female; Global Health; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Primary Prevention; acetylsalicylic acid; acetylsalicylic acid; antithrombocytic agent; adult; aged; Article; cardiovascular disease; controlled study; cross-sectional study; female; health survey; high income country; human; low income country; major clinical study; male; middle aged; middle income country; prevalence; primary prevention; cardiovascular disease; global health; procedures
Proyectos asociados
Breast cancer heterogeneity - etiology, clinical management, use of health resources and survival
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2022
Longitudinal Assessment of Cognitive Decline in Breast and Prostate Cancer Survivors
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico (Cognitive Decline) . 2022
Healthcare use among cancer patients and their partners in different phases of the cancer pathway
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2021
Reshaping organized cervical cancer screening: strategies to increase the adherence and reduce invitation costs
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Using pooled analyses based on individual participant data for a finer assessment of gastric cancer etiology
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
RISK AND SURVIVAL OF GASTRIC CANCER RELATES SECOND PRIMARY TUMOURS: A COMPETING RISKS FRAMEWORK
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2019
Citar a publicação
Yoo SGK,Chung GS,Bahendeka SK,Sibai AM,Damasceno A,Farzadfar F,Rohloff P,Houehanou C,Norov B,Karki KB,Azangou M,Marcus ME,Aryal KK,Brant LCC,Theilmann M,Cifkova R,Lunet N,Gurung MS,Mwangi JK,Martins J,Haghshenas R,Sturua L,Vollmer S,Barnighausen T,Atun R,Sussman JB,Singh K,Moghaddam SS,Guwatudde D,Geldsetzer P,Manne J,Huffman MD,Davies JI,Flood D. Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Glo. Heart. 2024. 19. (1):44. IF:3,700. (2).
